- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
QLT Inc+ Add to Watchlist
QLTI:US3.6700 USD 0.0900 2.39%
As of 20:10:00 ET on 06/01/2015.
Company Profile for QLT Inc (QLTI)
QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.
Key Executives for QLT Inc (QLTI)
|Jason M AryehChairman||Geoffrey F Cox "Geoff"Interim CEO|
|Glen IbbottInterim CFO/VP:Finance|